MedPath

Prospective,randomized clinical trial for homeostasis via hemospray after endoscopic resection in the upper gastrointestinal tract

Not Applicable
Recruiting
Conditions
Hemostasis after endoscopic resection of polyps in the stomach and duodenumhemostasis
C26.9
Ill-defined sites within the digestive system
Registration Number
DRKS00007951
Lead Sponsor
Sana Klinikum Offenbach
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients older than 18 years
- Patients with a lesion in the upper gastrointestinal tract and medical indication for resection .
- Bleeding complications ( bleeding Sure , spurting bleeding or bleeding with visible vessel )

Exclusion Criteria

- Lack of consent
- Pregnancy
- Coagulation disorders ( Quick < 60 % , PTT > 50s , platelets < 100,000 / nl )
- Taking antiplatelet < 7 days.
- Taking an oral anticoagulation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main objective of the study is to investigate whether an application of Hemospray © bleeding complication after endoscopic resection may reduce upper GI. Hemospray © Company Cook is already used in the therapy of acute bleeding complications of the upper and lower gastrointestinal tract. The question is whether the high rate is influenced to bleeding complications and postintervention bleeding. In steady course all occurring complications can be detected accurately, distinguishing between complications within the first 24 hours after surgery and complications occurring later. ,<br>In addition, a re-EGD is in each patient the day after the intervention performed in order to assess the wound surface, possibly to detect emerging local bleeding and endoscopically to breastfeed and possibly to treat small residual Adenomreste after. Again, any findings and any re-intervention in the frame of the documents.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath